These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 23103355)

  • 21. Ligands for cannabinoid receptors, promising anticancer agents.
    Nikan M; Nabavi SM; Manayi A
    Life Sci; 2016 Feb; 146():124-30. PubMed ID: 26764235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
    Oesch S; Gertsch J
    J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells.
    Boyacıoğlu Ö; Korkusuz P
    Adv Exp Med Biol; 2023; 1410():145-169. PubMed ID: 36396926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumour actions of cannabinoids.
    Hinz B; Ramer R
    Br J Pharmacol; 2019 May; 176(10):1384-1394. PubMed ID: 30019449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.
    Echigo R; Sugimoto N; Yachie A; Ohno-Shosaku T
    Oncol Rep; 2012 Oct; 28(4):1176-80. PubMed ID: 22842590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid receptor systems: therapeutic targets for tumour intervention.
    Jones S; Howl J
    Expert Opin Ther Targets; 2003 Dec; 7(6):749-58. PubMed ID: 14640910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemistry and pharmacology of endovanilloids.
    Starowicz K; Nigam S; Di Marzo V
    Pharmacol Ther; 2007 Apr; 114(1):13-33. PubMed ID: 17349697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neuropharmacology of cannabinoid receptor ligands in central signaling pathways.
    Brunt TM; Bossong MG
    Eur J Neurosci; 2022 Feb; 55(4):909-921. PubMed ID: 32974975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Endocannabinoid System: A Target for Cancer Treatment.
    Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers?
    Pushkarev VM; Kovzun OI; Tronko MD
    Exp Oncol; 2008 Mar; 30(1):6-21. PubMed ID: 18438336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular basis for neuroimmune receptor signaling.
    Rogers TJ
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):722-4. PubMed ID: 22935971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the endocannabinoid system: future therapeutic strategies.
    Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
    Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocannabinoids as Guardians of Metastasis.
    Tegeder I
    Int J Mol Sci; 2016 Feb; 17(2):230. PubMed ID: 26875980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of nonadrenergic noncholinergic neurotransmitter release via endocannabinoids: an in vitro study in rabbit corpus cavernosum.
    Vural IM; Ozturk GS; Sarioglu Y
    J Sex Med; 2009 Mar; 6(3):717-29. PubMed ID: 19175867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R; Hinz B
    J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer activity of anandamide in human cutaneous melanoma cells.
    Adinolfi B; Romanini A; Vanni A; Martinotti E; Chicca A; Fogli S; Nieri P
    Eur J Pharmacol; 2013 Oct; 718(1-3):154-9. PubMed ID: 24041928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.
    Pisanti S; Malfitano AM; Grimaldi C; Santoro A; Gazzerro P; Laezza C; Bifulco M
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):117-31. PubMed ID: 19285265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid signaling in glioma cells.
    Ellert-Miklaszewska A; Ciechomska I; Kaminska B
    Adv Exp Med Biol; 2013; 986():209-20. PubMed ID: 22879071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.